Hot Flashes Epidemiology Forecast 2025-2034

Hot flashes are considered the most common symptom of menopause, with an estimated 75% of women experiencing sudden, periodic spikes in their body temperature. Hot flashes last for 2 years or less for 80% of women, usually starting before the last period.

Hot Flashes Epidemiology Forecast Report Coverage

The “Hot Flashes Epidemiology Forecast Report 2034” offers comprehensive information on the prevalence and demographics of hot flashes. It projects the future incidence and prevalence rates of hot flashes across various populations.The study covers age, gender, and type as major determinants of the hot flashes-affected population. The report highlights patterns in the prevalence of hot flashes over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hot flashes in the 8 major markets, namely, the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India.

Regions Covered

• The United States
• EU-4 (Germany, France, Italy, Spain) and the United Kingdom
• Japan
• India

Hot Flashes: Disease Overview

Hot flash, a common symptom of menopause, is characterized by a sudden sensation of intense heat, usually in the upper body (face, neck, and chest). It can cause redness, sweating, and a rapid heartbeat. Hot flashes are linked with fluctuating hormones that occur before, during, and post-menopause and vary in duration, frequency, and severity. They can last for 6 months to several months and usually persist for less than 5 minutes. The mean duration of hot flashes is estimated to be 1.2 years.

Hot Flashes: Treatment Overview

For the treatment of hot flashes, lifestyle changes are usually encouraged before proceeding to hormonal or non-hormonal therapies. Systemic estrogen is reported as the most effective treatment for hot flashes, helping in a 75% reduction in the frequency of vasomotor symptoms. Progestin therapy at high doses also helps in reducing hot flashes. Progesterone treatment is recommended in women who cannot opt for estrogen therapy.

Epidemiology

The hot flashes epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for hot flashes by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hot flashes and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to a review published in the Journal of Midlife Health (2019), around 85% of women are affected by hot flashes during menopause. The symptoms last for 1 to 5 minutes and may cause significant distress when severe and frequent. Additionally, nearly 55% of women who enter the transition phase toward menopause experience hot flashes.
• Studies indicate that 65% of women are affected by hot flashes for more than 2 years, and approximately 36% experience them for over 5 years.
• Hot flashes are variable in terms of severity, with many women experiencing few or mild hot flashes. On the other hand, about 10% of the women experience more than 7 episodes of hot flashes in a day.
• Hot flashes differ across race and ethnicity, with Native American and Black women experiencing the most frequent and bothersome symptoms among all groups studied to date.

Country-wise Hot Flashes Epidemiology

The hot flashes epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of hot flashes differs between countries due to factors such as genetic differences, dietary and nutritional habits, and lifestyle patterns, among others. Various studies have revealed that the prevalence of hot flashes is affected by geographical boundaries, with the highest frequency of this condition seen among Turkish women (97%), followed by Australian (83%), European (76.5%), and North American women (58.8%). Further, it is reported that Indian women may experience hot flashes earlier as the menopausal age among Indian women is nearly 4 to 5 years lower than in Western women.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hot flashes based on several factors.
• Hot Flashes Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India)
• The report helps to identify the patient population, and the unmet needs of hot flashes are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of hot flashes epidemiology in the 8 major markets?
• What will be the total number of patients with hot flashes across the 8 major markets during the forecast period?
• What was the country-wise prevalence of hot flashes in the 8 major markets in the historical period?
• Which country will have the highest number of hot flash patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of hot flashes during the forecast period of 2025-2034?
• What are the currently available treatments for hot flashes?
• What are the disease risks, signs, symptoms, and unmet needs of hot flashes?

This product will be delivered within 3-5 business days.